NY
Times – The Trump administration
announced on Tuesday that it intended to end a Biden-era program that for the
past two years has helped tamp down the cost of monthly premiums for drug
coverage for people on Medicare.
The decision means that millions
of Americans 65 and older could face higher Medicare drug premiums next year,
when the cost of living is already a major concern. That could be politically
damaging for Republicans in the midterm elections. In the weeks leading up to
November, Medicare beneficiaries could experience sticker shock while shopping
for next year’s drug plan./
